Search

Your search keyword '"Drug Implants administration & dosage"' showing total 35 results

Search Constraints

Start Over You searched for: Descriptor "Drug Implants administration & dosage" Remove constraint Descriptor: "Drug Implants administration & dosage" Topic stents Remove constraint Topic: stents
35 results on '"Drug Implants administration & dosage"'

Search Results

1. Local sustained delivery of acetylsalicylic acid via hybrid stent with biodegradable nanofibers reduces adhesion of blood cells and promotes reendothelialization of the denuded artery.

2. [Drug eluting stents and anticoagulation in the perioperative setting - an interdisciplinary challenge].

3. Modelling drug elution from stents: effects of reversible binding in the vascular wall and degradable polymeric matrix.

4. [Drug-eluting coronary stents and drug eluting balloon catheters: summary of the position papers of the DGK].

5. Infrapopliteal application of paclitaxel-eluting stents for critical limb ischemia: midterm angiographic and clinical results.

6. The application of ink-jet technology for the coating and loading of drug-eluting stents.

7. Vascular pathology of drug-eluting stents.

8. Drug-eluting stents, restenosis and revascularization.

9. Biological effects of drug-eluting stents in the coronary circulation.

10. Angioscopic findings after drug-eluting stent implantation.

11. Review of the TAXUS Liberté SR paclitaxel-eluting coronary stent.

12. Coronary stents: a materials perspective.

13. Vascular delivery of c-myc antisense from cationically modified phosphorylcholine coated stents.

14. Early and intermediate-term outcomes with drug-eluting stents in high-risk patients with symptomatic intracranial stenosis.

15. [New study results in cardiology].

16. [The Nordic Bifurcation Study. Randomized study on the question of optimal stenting technique for bifurcating stenosis].

17. Regulatory issues facing the development of drug-eluting stents: a US FDA perspective.

18. Treatment of in-stent restenosis with sirolimus-eluting-stents -- a six month clinical and angiographic follow-up.

19. Polymer-based paclitaxel-eluting stent for treatment of chronic total occlusions of native coronaries: results of a Taxus CTO registry.

20. ISR II study: a long-term evaluation of sirolimus-eluting stent in the treatment of patients with in-stent restenotic native coronary artery lesions.

22. Programmable elution profile coating for drug eluting stents.

23. High-dose bolus tirofiban and sirolimus eluting stent versus abiciximab and bare metal stent in acute myocardial infarction (STRATEGY) study--protocol design and demography of the first 100 patients.

24. Drug eluting stents.

25. Drug loading and elution from a phosphorylcholine polymer-coated coronary stent does not affect long-term stability of the coating in vivo.

26. Sirolimus-eluting stent implantation in ST-elevation acute myocardial infarction: a clinical and angiographic study.

27. Randomized study to assess the effectiveness of slow- and moderate-release polymer-based paclitaxel-eluting stents for coronary artery lesions.

28. Paclitaxel coating reduces in-stent intimal hyperplasia in human coronary arteries: a serial volumetric intravascular ultrasound analysis from the Asian Paclitaxel-Eluting Stent Clinical Trial (ASPECT).

29. TAXUS III Trial: in-stent restenosis treated with stent-based delivery of paclitaxel incorporated in a slow-release polymer formulation.

30. Coated stents for the prevention of restenosis: Part II.

31. Images in Cardiovascular Medicine. True three-dimensional reconstructed images showing lumen enlargement after sirolimus-eluting stent implantation.

32. 7-hexanoyltaxol-eluting stent for prevention of neointimal growth: an intravascular ultrasound analysis from the Study to COmpare REstenosis rate between QueST and QuaDS-QP2 (SCORE).

33. Persistent inhibition of neointimal hyperplasia after sirolimus-eluting stent implantation: long-term (up to 2 years) clinical, angiographic, and intravascular ultrasound follow-up.

34. Sustained suppression of neointimal proliferation by sirolimus-eluting stents: one-year angiographic and intravascular ultrasound follow-up.

35. Living the dream of no restenosis.

Catalog

Books, media, physical & digital resources